The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical impact of expanded BRAF mutational status on the outcome for metastatic colorectal cancer patients with anti-EGFR antibody: An analysis of the BREAC trial (Biomarker Research for Anti-EGFR Monoclonal Antibodies by Comprehensive Cancer Genomics).
 
Kentaro Yamazaki
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Takayuki Yoshino
No Relationships to Disclose
 
Katsuya Tsuchihara
No Relationships to Disclose
 
Eiji Shinozaki
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Kei Muro
Speakers' Bureau - Bristol-Myers Squibb Japan; Merck Serono; Takeda; Yakult Honsha
 
Tomohiro Nishina
Speakers' Bureau - Merck Serono; Takeda; Yakult Honsha
 
Kensei Yamaguchi
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Merck Serono; Takeda
 
Kiwamu Akagi
No Relationships to Disclose
 
Satoshi Yuki
Speakers' Bureau - Bristol-Myers Squibb Japan; Merck Serono; Takeda; Yakult Honsha
 
Takeharu Yamanaka
Speakers' Bureau - Bristol-Myers Squibb Japan; Chugai Pharma; Taiho Pharmaceutical; Takeda
 
Shogo Nomura
Employment - Asahi Kasei
 
Satoshi Fujii
No Relationships to Disclose
 
Hiroyasu Esumi
No Relationships to Disclose
 
Yukiko Abe
No Relationships to Disclose
 
Atsushi Ohtsu
Employment - Celgene (I)